Swaminathan M, Ravandi F. Can measurable residual disease assessment be reliably used to defer allogeneic stem cell transplant in patients with intermediate-risk acute myeloid leukemia?. Haematologica 2023;108(10):2561-2563; https://doi.org/10.3324/haematol.2023.283120.